Lost in knowledge translation: time for a map?
ID Graham, J Logan, MB Harrison… - Journal of continuing …, 2006 - journals.lww.com
There is confusion and misunderstanding about the concepts of knowledge translation,
knowledge transfer, knowledge exchange, research utilization, implementation, diffusion, and …
knowledge transfer, knowledge exchange, research utilization, implementation, diffusion, and …
[HTML][HTML] Defining knowledge translation
• The knowledge-to-action framework provides a model for the promotion of the application
of research and the process of knowledge translation. have revealed that high-quality …
of research and the process of knowledge translation. have revealed that high-quality …
[HTML][HTML] World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
…, O Onuma, C Varghese, M Ezzati, I Graham… - The Lancet global …, 2019 - thelancet.com
Background To help adapt cardiovascular disease risk prediction approaches to low-income
and middle-income countries, WHO has convened an effort to develop, evaluate, and …
and middle-income countries, WHO has convened an effort to develop, evaluate, and …
European guidelines on cardiovascular disease prevention in clinical practice; third joint task force of European and other societies on cardiovascular disease …
…, S Ebrahim, O Faergeman, I Graham… - European Journal of …, 2003 - academic.oup.com
Preamble Guidelines aim to present all the relevant evidence on a particular issue in order
to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic …
to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic …
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and …
I Graham, D Atar, K Borch-Johnsen… - European heart …, 2007 - academic.oup.com
… Ian Graham, Dan Atar, Knut Borch-Johnsen, Gudrun Boysen, Gunilla Burell, Renata
Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph …
Cifkova, Jean Dallongeville, Guy De Backer, Shah Ebrahim, Bjørn Gjelsvik, Christoph …
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and …
…, AL Catapano, G De Backer, I Graham… - European heart …, 2011 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with
what is recommended in the guidelines, thus completing the loop between clinical research, …
what is recommended in the guidelines, thus completing the loop between clinical research, …
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
…, V Delgado, BA Ference, IM Graham… - European heart …, 2020 - academic.oup.com
version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals’ websites (EHJ and Atherosclerosis Journal). The National Cardiac …
hosted on their journals’ websites (EHJ and Atherosclerosis Journal). The National Cardiac …
[HTML][HTML] AGREE II: advancing guideline development, reporting and evaluation in health care
• The instrument successfully differentiates between highand low-quality guideline content. 7•
The new user’s manual is well received by users. 7• Users provided considerable …
The new user’s manual is well received by users. 7• Users provided considerable …
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the …
BA Ference, HN Ginsberg, I Graham… - European heart …, 2017 - academic.oup.com
Aims To appraise the clinical and genetic evidence that low-density lipoproteins (LDLs)
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …
cause atherosclerotic cardiovascular disease (ASCVD). Methods and results We assessed …
Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project
IM Graham, LE Daly, HM Refsum, K Robinson… - Jama, 1997 - jamanetwork.com
Context. —Elevated plasma homocysteine is a known risk factor for atherosclerotic vascular
disease, but the strength of the relationship and the interaction of plasma homocysteine with …
disease, but the strength of the relationship and the interaction of plasma homocysteine with …